Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Gemtuzumab price?

See the DrugPatentWatch profile for Gemtuzumab

What is the current price of gemtuzumab (Mylotarg) and what affects it?

Pricing for gemtuzumab is usually quoted as the cost per vial and varies by country, payer (hospital vs. insured patient), dose required by the patient’s weight, and the treatment setting. In practice, the “price” you’ll see depends on whether you’re looking at:
- Wholesale acquisition cost (WAC) or list price reported by the manufacturer
- A negotiated hospital/insurer contract price
- Patient out-of-pocket cost after insurance and copays

If you tell me your country (and whether you mean list price, insurance price, or out-of-pocket), I can narrow what “price” means for your situation.

How much gemtuzumab does a typical treatment course cost?

Gemtuzumab dosing is weight-based and given in cycles, so total spend scales with:
- Patient weight (which changes the mg per dose)
- Number of cycles planned
- Dose modifications for low blood counts or other toxicities

Because of this, the total course cost can differ substantially even when the per-vial price stays the same.

Why prices for gemtuzumab differ by where you buy it

Different countries regulate drug pricing and reimbursement differently, and hospitals often pay different prices than the public list price. Even within the same country, costs differ depending on whether administration happens in an inpatient vs. outpatient setting and whether there are bundled administration costs.

Are there cheaper alternatives that use the same target?

If your goal is cost comparison rather than the exact gemtuzumab price, the relevant comparison is to other acute myeloid leukemia (AML) treatment options used in similar clinical settings. Which alternative is “cheaper” depends on the line of therapy and the regimen chosen.

Can biosimilars or generic versions lower gemtuzumab cost?

Whether lower-cost competition exists depends on whether gemtuzumab has any eligible biosimilar/generic competition in your market. That varies by jurisdiction and product exclusivity status.

What I need from you to give an exact number

Share these and I can give the most relevant “gemtuzumab price” figure:
1) Country (e.g., US, UK, Canada, EU country)
2) Do you want list/WAC, hospital contract price, or patient out-of-pocket?
3) Are you asking about Mylotarg specifically, and do you know the vial size you’re looking at?

Sources

No sources were provided with your question, so I can’t cite an exact gemtuzumab price yet.



Other Questions About Gemtuzumab :

Can gemtuzumab ozogamicin be used for children?